Skip to content

Study of ayurvedic formulation in presbyopia

A randomized controlled clinical trial to assess effectiveness of narikeladi raskriya anjana with spectacular correction in dwitiya patalagata timir with reference to presbyopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038488
Enrollment
72
Registered
2021-12-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

Intervention1: Nalikera raskriya anjana: Topical (local application) once a day for 30 days Control Intervention1: Spectacular correction: Spectacular correction

Sponsors

Dr Darshana Chandrakant Kamble
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with the clinical symptoms of presbyopia (near vision less than N6 with best corrected distance vision). Patients of either sex within the age group of 35 to 55 years of age.

Exclusion criteria

Exclusion criteria: Presbyopia associated with systemic disorder or other ocular pathology. Presbyopia with cataract and post operative cataract patients. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Narikeladi raskriya anjana is effective in dwitiya patalagata Timir with reference to presbyopiaTimepoint: Follow up on 0th,7th,14th,30th and 60th day

Secondary

MeasureTime frame
Narikeladi raskriya anjana is not effective in dwitiya patalagata Timir with reference to presbyopiaTimepoint: Follow up on 0th,7th,14th,30th and 60th day

Countries

India

Contacts

Public ContactDr Dipti Sudhir Nene

Dr G D Pol Foundation YMTAMC

dipti.nene@gmail.com9987005997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026